CIR Tables Review Of Preservative PHMB; Industry Maintains Data Is On The Way

The Cosmetic Ingredient Review Expert Panel tabled a draft final report for preservative polyaminopropyl biguanide June 5 to await promised sensitization and exposure data from industry. There is concern that an “insufficient data” decision could prompt reformulations with even more questionable alternatives in a market short on preservative options.

waiting for the artist

Concerns about the prospect of questionable reformulations led the Cosmetic Ingredient Review Expert Panel to table a draft final report on preservative polyaminopropyl biguanide (PHMB) June 5, rather than tagging it with an “insufficient data” conclusion.

The move came after lengthy deliberation, with disagreement between the panel’s two teams, led by James Marks, dermatology professor at...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Ingredients & Safety

More from HBW Insight

L’Oréal, NVIDIA Partner To ‘Unlock’ AI’s Potential Across Beauty

 

L’Oréal SA and NVIDIA Corp. are collaborating to unlock AI’s potential access across beauty, including innovation, scalability, and personalized marketing, the French beauty firm and the tech company announced during the Viva Technology show in Paris.

Xlear Lawsuit Argues To Shelve FTC Policy For Health Claim Substantiation Under Loper Bright

 

Complaint filed Utah federal court says “Supreme Court explicitly rejected Chevron deference to agency interpretations” in the Loper decision, compelling rejection of “an agency’s statutory interpretation unless the court, ‘after applying all relevant interpretive tools, concludes’ the interpretatio

People On The Move: Appointments At Pharma Deutschland, AMA, FSA

 
• By 

A round-up of the latest people moves: Pharma Deutschland names head of new OTC Market division; the African Medicines Agency appoints director general; the UK's Food Standards Agency adds members to novel foods committee.